Home Online Features /R E P E A T -- Magnet-Like Nanoparticle Vaccine Achieves 100% Protection Against H5N1 in Preclinical Trials/
/R E P E A T — Magnet-Like Nanoparticle Vaccine Achieves 100% Protection Against H5N1 in Preclinical Trials/
Press Releases
April 21, 2025

/R E P E A T — Magnet-Like Nanoparticle Vaccine Achieves 100% Protection Against H5N1 in Preclinical Trials/

By BioNiagara

BUFFALO-NIAGARA, N.Y., April 17, 2025 /PRNewswire/ - As H5N1 avian influenza continues its spread across species and continents, a vaccine being developed by University of Buffalo (SUNY) spin-off POP Biotechnologies

bradford

The Bradford Era

email
More by this Author
Local & Social